| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.08 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.08 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.08 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.08 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.059 | 0.09 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.051 | 0.09 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.09 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.23 | 0.09 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.09 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.059 | 0.09 |